Targeting KRAS inhibitor resistance by ferroptosis induction in PDAC

被引：0
|
作者：
Padhye, Aparna
Yu, Qijia
Sindoni, Nicole
Zhang, Huan
Dilly, Julien
Feng, Hanrong
Aguirre, Andrew
Mancias, Joseph
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-C018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C018
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Research progress on small molecule inhibitors targeting KRAS G12C with acrylamide structure and the strategies for solving KRAS inhibitor resistance
    Jiang, Zhiyan
    Li, Yan
    Zhou, Xin
    Wen, Jie
    Zheng, Pengwu
    Zhu, Wufu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
  • [23] SOS1 inhibitor combinations overcome KRAS inhibitor resistance
    Hofmann, Marco H.
    Jurado, Sabine
    NATURE CANCER, 2024, 5 (09) : 1294 - 1295
  • [24] Identifying synergistic combinations with KRAS inhibition in PDAC
    Thege, Fredrik I.
    Hoskins, Amber
    Woermann, Sonja M.
    Maitra, Anirban
    CANCER RESEARCH, 2024, 84 (17)
  • [25] Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
    Jing Cai
    Xiaoding Xu
    Phei Er Saw
    Science China Life Sciences, 2024, 67 : 19 - 40
  • [26] Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
    Cai, Jing
    Xu, Xiaoding
    Saw, Phei Er
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (01) : 19 - 40
  • [27] Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
    Jing Cai
    Xiaoding Xu
    Phei Er Saw
    Science China(Life Sciences), 2024, 67 (01) : 19 - 40
  • [28] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 1210 - 1210
  • [29] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 783 - 783
  • [30] Targeting chromatin regulation in PDAC
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2015, 14 (11) : 750 - 750
12345